Oncternal Therapeutics Inc (NASDAQ:ONCT)

0.8654
BATS BZX Real-Time Price
As of 2:29pm ET
 +0.0844 / +10.81%
Today’s Change
0.69
Today|||52-Week Range
4.60
-61.88%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Oncternal Therapeutics Inc have a median target of 9.50, with a high estimate of 15.00 and a low estimate of 3.50. The median estimate represents a +997.76% increase from the last price of 0.87.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Oncternal Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$305.8K
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.90%
 
 
 
 
 
 
Growthannually -41.67%
 
 
 
 
 
 

Sales

Growthquarterly 60.10%
 
 
 
 
 
 
Growthannually -63.80%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.